The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.
Lima K, Pereira-Martins DA, de Miranda LBL, Coelho-Silva JL, Leandro GDS, Weinhäuser I, Cavaglieri RC, Leal AM, da Silva WF, Lange APAL, Velloso EDRP, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Rego EM, Machado-Neto JA.
Lima K, et al. Among authors: de miranda lbl.
Blood Cancer J. 2022 Nov 9;12(11):151. doi: 10.1038/s41408-022-00747-w.
Blood Cancer J. 2022.
PMID: 36347832
Free PMC article.